Aminopterin/methotrexate embryofetopathy

A syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.

Micromelia

The presence of abnormally small extremities.


Total: 0

                      


(per page)
PMID (PMCID)